Archimedes Inc. is a healthcare modeling organization. Its core technology - the Archimedes Model - is a clinically realistic, mathematical model of human physiology, diseases, interventions and healthcare systems. The Model is continually validated by comparing the results of simulated trials to the results of real multi-national clinical trials and cohort studies.
Through innovations such as IndiGO and ARCHeS, Archimedes he...
Archimedes Inc. is a healthcare modeling organization. Its core technology - the Archimedes Model - is a clinically realistic, mathematical model of human physiology, diseases, interventions and healthcare systems. The Model is continually validated by comparing the results of simulated trials to the results of real multi-national clinical trials and cohort studies.
Through innovations such as IndiGO and ARCHeS, Archimedes helps people understand the implications of their decisions and for the last 15 years has been relied upon to answer complex, real world questions for health plans, health systems, medical groups, and pharmaceutical companies, researchers, and other organizations in the US and Europe. Archimedes, a Kaiser Permanente Innovation, is based in San Francisco, California.
The Archimedes story began in 1992 when David Eddy, MD PhD, then a consultant to the Southern California region of Kaiser Permanente (KPSC), approached the clinical and health plan leaders of KPSC, Frank Murray and Hugh Jones, with the idea of building a clinically realistic, large scale simulation model of physiology, populations, and health care systems. The objective was to provide decision makers at KPSC with quantitative information about the outcomes they could expect from different clinical and administrative policies and programs.
From his past experience building models, Eddy knew that a fundamentally different type of healthcare model would be needed. Frank Murray and Hugh Jones saw the value of the idea and committed the funds. Shortly thereafter Len Schlessinger, PhD, was recruited to put together a small team to begin building the model.
It took several years to develop and test a new modeling method capable of achieving the level of detail and scope required to address the types of questions that arise in real clinical settings. A critical moment came in 2000 when the model was sufficiently well developed to set up to simulate real clinical trials.
In 2014, Archimedes was acquired by Evidera, Inc., a leading provider of evidence-based solutions for the healthcare industry. Along with the existing team of scientists, medical directors, and software engineers, this acquisition provided additional resources and expertise to continually update the Model, expand it to other disease areas, and enhance overall capabilities with Evidera’s core service areas, including health economics, outcomes research, market access, payer research, data analytics and epidemiology. Joining Evidera has also expanded the opportunity to serve our clients on a broader international scope.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.